EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Biology of factor XI

Samantha A Moellmer iD, Cristina Puy iD, Owen J T McCarty iD

Blood · 2024

DOI: 10.1182/blood.2023020719 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood, 2024. Verfasst von Samantha A Moellmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR. Hauptthemen laut MEDLINE: Factor XI, Factor XI Deficiency. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unique among coagulation factors, the coagulation factor XI (FXI) arose through a duplication of the gene KLKB1, which encodes plasma prekallikrein. This evolutionary origin sets FXI apart structurally because it is a homodimer with 2 identical subunits composed of 4 apple and 1 catalytic domain. Each domain exhibits unique affinities for binding partners within the coagulation cascade, regulating the conversion of FXI to a serine protease as well as the selectivity of substrates cleaved by the active form of FXI. Beyond serving as the molecular nexus for the extrinsic and contact pathways to propagate thrombin generation by way of activating FIX, the function of FXI extends to contribute to barrier function, platelet activation, inflammation, and the immune response. Herein, we critically review the current understanding of the molecular biology of FXI, touching on some functional consequences at the cell, tissue, and organ level. We conclude each section by highlighting the DNA mutations within each domain that present as FXI deficiency. Together, a narrative review of the structure-function of the domains of FXI is imperative to understand the etiology of hemophilia C as well as to identify regions of FXI to safely inhibit the pathological function of activation or activity of FXI without compromising the physiologic role of FXI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor XIFactor XI DeficiencyHumansBlood CoagulationCatalytic DomainThrombinBiology

Substanzen

Factor XIThrombin

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.

ORCID-Profile: Samantha A Moellmer, Cristina Puy, Owen J T McCarty

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Moellmer, S. A., Puy, C., & McCarty, O. J. T. (2024). Biology of factor XI. Blood. https://doi.org/10.1182/blood.2023020719

Vancouver

Moellmer SA, Puy C, McCarty OJT. Biology of factor XI. Blood. 2024. doi:10.1182/blood.2023020719

BibTeX
@article{Moellmer2024,
  author = {Moellmer, Samantha A and Puy, Cristina and McCarty, Owen J T},
  title = {Biology of factor XI},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2023020719}
}
Kostenlos starten →